Lung cancer Posts - Page 52 of 52 on Medivizor
Navigation Menu

Lung cancer Posts on Medivizor

Maintenance therapy after bevacizumab and chemotherapy treatment in advanced non–small cell lung cancer patients

Posted by on Aug 4, 2013 in Lung cancer | 0 comments

In a nutshell This phase III trial compared two maintenance therapy strategies in the treatment of advanced non–small cell lung cancer (NSCLC) patients. The effect of bevacizumab (Avastin) was compared to that of combined bevacizumab and pemetrexed (Alimta) treatment. Some background Chemotherapy is one of the main strategies applied in the...

Read More

Smoking cessation after the diagnosis of lung cancer

Smoking cessation after the diagnosis of lung cancer

Posted by on Aug 4, 2013 in Lung cancer | 0 comments

In a nutshell This review analyzed data collected from recent studies, and estimated the effect of smoking cessation after diagnosis on the outcome of lung cancer patients. Some background Smoking is known to increase the risk of developing lung cancer, as well as other life threatening medical conditions. Quitting smoking after the diagnosis of...

Read More

Ipilimumab with paclitaxel and carboplatin as first-line therapy in extensive disease small cell lung cancer

Posted by on Aug 4, 2013 in Lung cancer | 0 comments

In a nutshell This study investigated the effects of ipilimumab (Yervoy) in combination with chemotherapy in the treatment of extensive disease small-cell lung cancer (ED-SCLC). Some background Ipilimumab is a drug used to modify the behavior of the immune system. Ipilimumab acts against regulatory immune cells (cells that inhibit the action of...

Read More

Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR-positive non-small cell lung cancer

Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR-positive non-small cell lung cancer

Posted by on Aug 4, 2013 in Lung cancer | 0 comments

In a nutshell This phase III trial compared chemotherapy to erlotinib (Tarceva) as first line treatment for EGFR-positive non-small cell lung cancer (NSCLC) patients. The safety and efficacy of the treatments were compared to decide which treatment is most beneficial for advanced cancer patients. Some background Non-small-cell lung cancer (NSCLC)...

Read More

Hide and Go Seek…Continues: Prevalence

Hide and Go Seek…Continues: Prevalence

Posted by on May 13, 2013 in Benign prostatic hyperplasia, Blog, Breast cancer, Colorectal cancer, Coronary artery disease, Diabetes mellitus, Erectile dysfunction, Hodgkin's lymphoma, Hypertension, Infertility, Kidney stones, Leukemia, Lung cancer, Lymphoma, Melanoma, Multiple Myeloma, Non-Hodgkin lymphoma, Prostate cancer, Rheumatoid Arthritis, Stroke, Urinary incontinence, Urinary tract infection | 1 comment

Deep Breathing Time Again… We’re about to seek the answer to another of the numbers that health and medical professionals use daily from statistics. Are you ready?  Here it goes… What does Prevalence Rate in Statistics Mean? The prevalence rate is the total number of cases of a disease in a specific population divided by the total number of people...

Read More

Count to 10… then Hide: Incidence! Understanding Statistics

Count to 10… then Hide: Incidence! Understanding Statistics

Posted by on May 7, 2013 in Benign prostatic hyperplasia, Blog, Breast cancer, Colorectal cancer, Coronary artery disease, Diabetes mellitus, Erectile dysfunction, Hodgkin's lymphoma, Hypertension, Infertility, Kidney stones, Leukemia, Lung cancer, Lymphoma, Melanoma, Multiple Myeloma, Non-Hodgkin lymphoma, Prostate cancer, Rheumatoid Arthritis, Stroke, Urinary incontinence, Urinary tract infection | 6 comments

Ready to play Hide and Seek? Or are you just ready to hide? Most people feel like hiding when faced with the numbers that health and medical professionals use daily, statistics.   So we’re going to start slowly and cover different mathematical concepts you might have heard.  This will be a series of posts so if there are any math concepts that you...

Read More